Similar articles

• Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.

  Lish PM, Labudde JA, Peters EL, Robbins SI. Lish PM, et al. Arch Int Pharmacodyn Ther. 1965 Aug;156(2):467-88. Arch Int Pharmacodyn Ther. 1965. PMID: 4380481 No abstract available.
• Comparative quantitative studies on cholinolytics. 3. The action of propanteline, methanteline, oxyphenonium and diphemanil.

  Wilimowski M, Orzechowska K, Prandota J, Barczyńska J. Wilimowski M, et al. Arch Immunol Ther Exp (Warsz). 1970;18(1):139-42. Arch Immunol Ther Exp (Warsz). 1970. PMID: 4392419 No abstract available.
• Studies on the nonspecific blocking action of benzyltrimethylammonium bromide (BTM).

  Dretchen K, Diecke FP, Long JP. Dretchen K, et al. J Pharmacol Exp Ther. 1971 May;177(2):369-76. J Pharmacol Exp Ther. 1971. PMID: 4398188 No abstract available.
• Uropharmacology: part VI. Parasympathetic depressants.

  Finkbeiner AE, Bissada NK, Welch LT. Finkbeiner AE, et al. Urology. 1977 Nov;10(5):503-10. doi: 10.1016/0090-4295(77)90149-2. Urology. 1977. PMID: 21482 Review.
• Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives.

  Moore H, Dudchenko P, Comer KS, Bruno JP, Sarter M. Moore H, et al. Psychopharmacology (Berl). 1992;108(1-2):241-3. doi: 10.1007/BF02245315. Psychopharmacology (Berl). 1992. PMID: 1410143 Review. No abstract available.